Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease (Q43760561)

26 November 2017

Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease (English)

1 reference

26 November 2017

0 references

W Herrmann

1

1 reference

26 November 2017

H Schorr

series ordinal

2

1 reference

26 November 2017

J Geisel

series ordinal

3

1 reference

26 November 2017

W Riegel

series ordinal

4

1 reference

26 November 2017

language of work or name

1 reference

1 August 2001

1 reference

Clinical Chemistry and Laboratory Medicine

26 November 2017

1 reference

26 November 2017

39

1 reference

26 November 2017

739-746

1 reference

26 November 2017

8

1 reference

Hyperhomocysteinaemia as a cardiovascular risk factor: an update

26 November 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

21 January 2018

Homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

The metabolism of homocysteine: pathways and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Homocysteine and methionine metabolism in ESRD: A stable isotope study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.123

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.123

1 reference

26 November 2017

1 reference